| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.05 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.078 | 0.05 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.14 | 0.05 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.05 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.05 |